Alt5 Sigma Etf Profile
| ALTS Etf | USD 4.64 0.55 13.45% |
PerformanceModest
| Odds Of DistressQuite High
|
ALT5 Sigma is selling for under 4.64 as of the 16th of March 2025; that is 13.45% increase since the beginning of the trading day. The etf's lowest day price was 4.0. ALT5 Sigma has more than 63 % chance of experiencing financial distress in the next few years of operation. It also did not have a very good performance during the last 90 trading days. ALT5 Sigma symbol was changed from JAN on 15th of July 2024. The performance scores are derived for the period starting the 16th of December 2024 and ending today, the 16th of March 2025. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 7th of November 1991 | Category Technology | Classification Health Care |
The fund is a fund of ETFs and seeks to achieve its investment objective by investing primarily in the underlying ETFs. ProShares Morningstar is traded on BTS Exchange in the United States. The company has 13.49 M outstanding shares of which 235.02 K shares are presently shorted by private and institutional investors with about 0.74 trading days to cover. More on ALT5 Sigma
Moving against ALT5 Etf
ALT5 Etf Highlights
| Older Symbol | JAN |
| CEO and Presidentident | Tony Isaac |
| Old Name | Altus Strategies PLC |
| Business Concentration | Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Pharmaceuticals, Waste Management, Industrials (View all Sectors) |
| Tax Provision | (429,000) |
| Total Current Liabilities | 5.91 Million |
| Total Stockholder Equity | (3.31 Million) |
| Currency Code | USD |
| Fiscal Year End | December |
| Stock Based Compensation | 14,000 |
| Begin Period Cash Flow | 115,000 |
| Net Debt | 702,000 |
| Accounts Payable | 2.27 Million |
| Cash | 5,000 |
| Non Current Assets Total | 18.14 Million |
| Non Currrent Assets Other | 9,000 |
| Quarterly Earnings Growth Y O Y | 1.187 |
| Long Term Debt | 707,000 |
| 50 Day M A | 2.0684 |
| Code | ALTS |
| Common Stock Shares Outstanding | 4.96 Million |
| Country Name | USA |
| Net Interest Income | 2.25 Million |
| Investments | (155,000) |
| Free Cash Flow | 1.46 Million |
| Net Invested Capital | (2.6 Million) |
| Depreciation | 1.45 Million |
| Operating Income | (4.75 Million) |
| 200 Day M A | 2.0463 |
| Currencysymbol | USD |
| Shares Float | 12.04 Million |
| Total Current Assets | 346,000 |
| Capital Stock | 3,000 |
| Non Current Liabilities Other | 34,000 |
| Updated At | 26th of February 2025 |
| Income Before Tax | (17.52 Million) |
| Type | Common Stock |
| I P O Date | 7th of November 1991 |
ALT5 Sigma [ALTS] is traded in USA and was established 2014-10-07. ALT5 Sigma was previously known as JAN Old and was traded on NASDAQ Exchange under the symbol JAN. ALT5 Sigma is listed under Pharmaceuticals category by Fama And French industry classification. The fund is listed under Health Care category and is part of Pharmaceuticals family. ALT5 Sigma presently have 18.49 M in assets under management (AUM). , while the total return for the last 3 years was 5.0%.
ALT5 Sigma generates positive cash flow from operations, but has no cash available
Check ALT5 Sigma Probability Of Bankruptcy
Sector Allocation
Investors will always prefer to have their portfolios divercified against different sectors. The broad sector allocation increases the possibility of making a profit or at least avoiding a loss. However, this may also reduce the expected return on ALT5 Etf. Generally, it depends on diversification level and type but usually, the broader the sector allocation, the less risk can be expected from holding ALT5 Etf, and the less return is expected.
Institutional investors that are interested in enforcing a sector tilt in their portfolio can use exchange-traded funds, such as ALT5 Sigma Etf, as a low-cost alternative to building a custom portfolio. So, using sector ETFs to diversify your portfolio can be a profitable strategy. However, no matter what sectors are desirable at a given time, no single industry should ever make up more than 20 percent of your stock portfolio.
Top ALT5 Sigma Etf Constituents
| HDG | ProShares Hedge Replication | Etf | Multistrategy | |
| MRGR | ProShares Merger ETF | Etf | Event Driven | |
| PEX | ProShares Global Listed | Etf | Miscellaneous Sector | |
| RINF | ProShares Inflation Expectations | Etf | Nontraditional Bond | |
| TOLZ | ProShares DJ Brookfield | Etf | Infrastructure |
ALT5 Sigma Risk Profiles
The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in ALT5 Sigma. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures.
| Risk Adjusted Performance | 0.1143 | |||
| Jensen Alpha | 1.05 | |||
| Total Risk Alpha | 1.89 | |||
| Sortino Ratio | 0.164 |
ALT5 Sigma Against Markets
Other Information on Investing in ALT5 Etf
ALT5 Sigma financial ratios help investors to determine whether ALT5 Etf is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in ALT5 with respect to the benefits of owning ALT5 Sigma security.